Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Le Blanc

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Cytotherapy|December 9, 2003
Immunomodulatory effects of fetal and adult mesenchymal stem cellsK Le Blanc
Cytotherapy|December 7, 2006
Mesenchymal stromal cells: Tissue repair and immune modulationK Le Blanc
Journal of Internal Medicine|October 24, 2007
Immunomodulation by mesenchymal stem cells and clinical experienceK Le Blanc, O Ringdén
Best Practice & Research. Clinical Haematology|March 15, 2011
Mesenchymal stem cells for treatment of acute and chronic graft-versus-host disease, tissue toxicity and hemorrhagesO Ringden, K Le Blanc
Cytotherapy|July 26, 2005
Mesenchymal stem cells: progress toward promiseK Le Blanc, Mf Pittenger
Clinical and Experimental Immunology|June 10, 2010
Immunotherapy prospects for acute myeloid leukaemiaA J Barrett, K Le Blanc
British Journal of Haematology|January 29, 2000
Marked heterogeneity in protein levels and functional integrity of the thrombopoietin receptor c-mpl in polycythaemia veraK Le Blanc, P Andersson, J Samuelsson
European Journal of Haematology|September 1, 1994
Stimulus-specific defect in platelet aggregation in polycythemia veraK Le Blanc, A Berg, J Palmblad, et al.
Cytotherapy|January 20, 2009
Optimizing in vitro conditions for immunomodulation and expansion of mesenchymal stromal cellsH Samuelsson, O Ringdén, H Lönnies, et al.
European Journal of Haematology|November 25, 2000
Defective platelet aggregation in polycythaemia vera is not caused by impaired calcium signaling, phospholipase D activation or decreased amounts of focal adhesion proteinsK Le Blanc, A Berg, J Palmblad, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Cytotherapy|December 9, 2003
Immunomodulatory effects of fetal and adult mesenchymal stem cellsK Le Blanc
Cytotherapy|December 7, 2006
Mesenchymal stromal cells: Tissue repair and immune modulationK Le Blanc
Journal of Internal Medicine|October 24, 2007
Immunomodulation by mesenchymal stem cells and clinical experienceK Le Blanc, O Ringdén
Best Practice & Research. Clinical Haematology|March 15, 2011
Mesenchymal stem cells for treatment of acute and chronic graft-versus-host disease, tissue toxicity and hemorrhagesO Ringden, K Le Blanc
Cytotherapy|July 26, 2005
Mesenchymal stem cells: progress toward promiseK Le Blanc, Mf Pittenger
Clinical and Experimental Immunology|June 10, 2010
Immunotherapy prospects for acute myeloid leukaemiaA J Barrett, K Le Blanc
British Journal of Haematology|January 29, 2000
Marked heterogeneity in protein levels and functional integrity of the thrombopoietin receptor c-mpl in polycythaemia veraK Le Blanc, P Andersson, J Samuelsson
European Journal of Haematology|September 1, 1994
Stimulus-specific defect in platelet aggregation in polycythemia veraK Le Blanc, A Berg, J Palmblad, et al.
Cytotherapy|January 20, 2009
Optimizing in vitro conditions for immunomodulation and expansion of mesenchymal stromal cellsH Samuelsson, O Ringdén, H Lönnies, et al.
European Journal of Haematology|November 25, 2000
Defective platelet aggregation in polycythaemia vera is not caused by impaired calcium signaling, phospholipase D activation or decreased amounts of focal adhesion proteinsK Le Blanc, A Berg, J Palmblad, et al.
Pageof 4